🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Peter Mesenbrink

Novartis (Switzerland)

ORCID: 0000-0002-5624-6726

Also affiliated with Novartis (China)

MedicineMathematicsBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 3 papers. Top paper: Rivastigmine in Alzheimer Disease.

Rivastigmine in Alzheimer Disease

The American Journal of Geriatric Psychiatry(2004)10.1097/00019442-200407000-00010
N/A
0.564DataRank · unranked
42 citations

Peter Irwin, Andrew Satlin, Peter Mesenbrink, René Spiegel, George Grossberg

10 citations

Joel B. Greenhouse, Danelle F. James, David Ohlssen, Peter Mesenbrink, Robin Dunn

6 citations

Peter Mesenbrink, Rui Jin, Erik B. Dam, Leticia A. Deveza, F. Eckstein +10 more